ROANOKE ASSET MANAGEMENT CORP/ NY - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROANOKE ASSET MANAGEMENT CORP/ NY ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$272
+22.5%
10,0000.0%0.11%
+27.3%
Q2 2023$222
+2.3%
10,0000.0%0.09%
-5.4%
Q1 2023$217
-28.9%
10,000
-33.3%
0.09%
-33.1%
Q4 2022$305
-99.9%
15,0000.0%0.14%
-24.0%
Q3 2022$385,000
+7.8%
15,0000.0%0.18%
+14.4%
Q2 2022$357,000
-20.7%
15,000
-25.0%
0.16%
-4.8%
Q1 2022$450,00020,0000.17%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders